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ABSTRACT
Many recent microarrays hold an enormous
number of probe sets, thus raising many practical
and theoretical problems in controlling the false
discovery rate (FDR). Biologically, it is likely that
most probe sets are associated with un-expressed
genes, so the measured values are simply noise
due to non-specific binding; also many probe sets
are associated with non-differentially-expressed
(non-DE) genes. In an analysis to find DE genes,
these probe sets contribute to the false discoveries,
so it is desirable to filter out these probe sets prior
to analysis. In the methodology proposed here, we
first fit a robust linear model for probe-level
Affymetrix data that accounts for probe and array
effects. We then develop a novel procedure called
FLUSH (Filtering Likely Uninformative Sets of
Hybridizations), which excludes probe sets that
have statistically small array-effects or large resid-
ual variance. This filtering procedure was evaluated
on a publicly available data set from a controlled
spiked-in experiment, as well as on a real experi-
mental data set of a mouse model for retinal
degeneration. In both cases, FLUSH filtering
improves the sensitivity in the detection of DE
genes compared to analyses using unfiltered, pre-
sence-filtered, intensity-filtered and variance-fil-
tered data. A freely-available package called
FLUSH implements the procedures and graphical
displays described in the article.
INTRODUCTION
Aﬀymetrix arrays are widely used for comparing the
expression of tens of thousands of genes under diﬀerent
experimental or clinical conditions. The number of probes
on these arrays continues to increase: for example, the
most recent releases of human chip array HGU133plus
holds 54000 probe sets, representing almost 40000 genes.
Nevertheless, not all genes are expected to be expressed at
biologically meaningful or at detectable levels (1–3 RNA
copies per cell), as most tissues express only 30–40% of the
genes (1) or, according to a recent estimation, around
10000–15000 genes (2). Furthermore, among the
expressed genes, generally only a very small fraction is
expected to be diﬀerentially expressed (DE) under
diﬀerent experimental conditions. This situation leads to
several problems, including measurement bias, increased
potential for false discoveries and reduced sensitivity in
detecting DE genes.
Measurement bias occurs because arrays with more
probes tend to have more spurious hybridizations,
particularly through non-speciﬁc binding of abundant
RNAs from highly expressed genes to the probes
associated with under- or un-expressed genes. For these
genes, random ﬂuctuation generates spuriously large test
statistics, which will then increase the number of false
discoveries. Additional problems in real data include an
unbalanced proportion of over- and under-expressed
genes, especially in laboratory experimental conditions.
This may introduce a severe bias in measurements due
to the normalization step, which typically assumes that
there is a balanced number of over- and under-expressed
genes. This bias carries over to the statistical analysis,
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rate (FDR), especially among the non-DE genes (3).
Presently there is no general guidance on whether or not
one should ﬁlter microarray data, hence many analyses
simply include all the genes. Even without the problem of
bias in the normalization step, it is intuitively clear that
including many non-DE genes in the collection of genes to
be tested will reduce the sensitivity in ﬁnding DE genes.
In technical terms, we say that the non-DE genes
contribute to the FDR of the procedure, so ﬁltering out
likely non-DE genes prior to statistical comparison will
help increase the sensitivity of the procedure.
The key idea in gene ﬁltering is to use features of the
data that do not directly use the information about the
experimental conditions. Many papers have reported
ﬁltering based on various approaches, such as average
intensity signal (4), within-gene signal variance (5–7),
percent present-calls (8), estimated fold-change or combi-
nations of various methods (9–10). Nevertheless,
at present little attention has been devoted to deeper
analysis of the raw data and the impact of pre-ﬁltering of
genes on the test procedures’ performance.
In this article, we propose a new algorithm to ﬂexibly
ﬁlter likely uninformative sets of hybridizations (FLUSH).
The method is based on a robust linear model of the
probe-level data that captures array and probe set eﬀects.
For our purposes, the model yields estimates of array-to-
array and residual variation. Probe sets with low array-to-
array variation are not likely to carry important biological
signal, so they are not likely to be DE and should be
ﬁltered out. Furthermore, probe sets with an elevated
residual variance typically tend to have inconsistent
patterns in the probe-eﬀect across replicate samples of
the experiment. These probe sets are mostly associated
with un-expressed genes, and again should be ﬁltered out.
The FLUSH procedure has been tested on a freely
available spike-in experiment as well as on real experi-
mental data on retinal degeneration. We compare the
performance of ﬁltered analyses with analyses using
unﬁltered, presence-ﬁltered, intensity-ﬁltered and var-
iance-ﬁltered data. Eliminating potentially uninformative
features reduces bias and increases sensitivity in ﬁnding
DE genes.
METHODS
Expression data pre-processing
Both spike-in data and experimental data were
pre-processed, prior to statistical testing, with two of the
most widely used procedures for background correction,
normalization and expression measure computation,
i.e. MAS5 (11) and RMA (12). Expression values
were analyzed on a logarithmic scale. For comparison,
ﬁltering based on Aﬀymetrix presence-calls was also used,
where features with less than 50% presence-calls were
excluded (13).
Golden Spike data. A ‘spike-in’ experiment for Aﬀymetrix
arrays designed by (14) provides a data set of 3860
RNA species, where 100–200 RNAs were spiked in at
fold-change (FC) level, ranging from 1.2 to 4-fold, while
a set of 2551 RNA species was spiked-in at a constant
(FC=1) level. Data were designed as a two-group
comparison, spike-in (S) versus control (C) (n=3 in
each group), with overall 9.5% genes over-expressed in S
versus C. Out of 14010 probe sets (DrosGenome1 chip),
1331 had FC>1, among which 650 had FC>2, 2535 had
FC=1 and 10131 were declared ‘empty’, where empty
means fewer than three perfect-match sequences matching
to any clone transcript present in the hybridization pools.
Experimental data. All experiments involving animals
were performed according to ARVO guidelines,
using C3H rd1/rd1 and wild-type mice obtained from
heterozygous animals; these were kindly provided by Theo
van Veen and are described in Viczian et al. (15).
Chemicals were obtained from Sigma-Aldrich (St Louis,
MO, USA) unless stated otherwise. At post-natal
day (PN) 15, three independent sets of 5 rd1 animals
(on a C3H genetic background) and three wild-type C3H
control sets (congenic animals) of ﬁve animals were
sacriﬁced, enucleated and immediately washed in PBS.
The retinas were peeled oﬀ and stored in guanidium
hydrochloride buﬀer (16). Retinas from each set of ﬁve
animals were combined in order to obtain suﬃcient
quantities of extracted RNA, and the independent
replicate sets are considered as biological replicates.
So, we have n=3 replicates in each of the mutant and
wild-type groups.
Retina RNA was isolated using the protocol described
in Glisin et al. (17). Brieﬂy, batches of 10 retina samples
(corresponding to each set of ﬁve animals) were homo-
genized using a Polytron (Kinematica, Littau-Lucerne,
Switzerland), centrifuged to remove debris, re-buﬀered in
N-lauryl sarcosine and centrifuged in a CsCl gradient
using a Beckman Coulter (Fullerton, CA) ultracentrifuge.
Dried pellets were dissolved in 10 mM Tris pH 7.5, 1 mM
EDTA, 0.1% SDS and precipitated using ethanol and 0.3
M NaAcetate. The resulting pellets were washed and
dissolved in DEPC-treated H2O. All samples were
checked for RNA quantity and quality, based on OD
260/280 and denaturing formaldehyde agarose gel electro-
phoresis (data not shown). Samples for hybridization to
Aﬀymetrix (Santa Clara, CA, USA) GeneChips were
prepared according to the manufacturers recommenda-
tions and hybridized to MG430.2 arrays.
Normalization. The normalization procedure adopted by
the MAS5 algorithm is a standard ‘global normalization’
applied on previously background corrected and
summarized expression values. Each array is rescaled to
have a mean equal to some reference array. RMA
normalization is performed after background correction
but before summarization. The intensity distribution from
every array is reshaped to follow the distribution of some
reference array (e.g. a synthetic array computed taking
the median of each features across arrays).
Differentially expressed genes identification. DE genes
were identiﬁed by means of a standard t-test for two
independent samples (e.g. group S versus group C for the
e102 Nucleic Acids Research, 2007, Vol. 35, No. 16 PAGE2 OF10Golden Spike data). Genes were then ranked according
to the false discovery rate (fdr) statistics. Local fdr were
computed according to the algorithm for false discovery
rate (fdr) computation proposed by Ploner et al. (18). The
local fdr can be interpreted as the expected proportion of
false positives if genes with an observed value t of the
given statistic (in our case the standard t-statistic) are
declared DE or, alternatively, as the posterior probability
of a gene being non-DE. This method is an extension of
the fdr concept to draw multidimensional fdr (fdr 2D),
using information coming from two sources, namely the t-
statistic and its associated standard error. The main
motivation is to protect against genes with small error
variance, as these genes are likely to be false positives. We
will make a distinction between local fdr (in lower case),
which applies to individual genes, and the standard global
FDR (in upper case), which applies to a collection of
genes. The term ‘FDR’ is also used as a generic
abbreviation.
The model
Data were modeled at the probe level. Each probe set may
contain from 8 to 20 pairs of perfect match (PM) and
mismatch (MM) probes. The model was ﬁtted on the PM
data (on the log2 scale) after background correction using
the so-called ideal mismatch (IMM) (11) to ensure positive
values. For a speciﬁc gene, we have the model
log2ðPMij   IMMijÞ¼ i þ  j þ  ij, 1
where  i is the ith array eﬀect, for i ¼ 1,...,n, and  j is the
jth probe eﬀect for j ¼ 1,...,J. The model was ﬁtted
through a robust linear model ﬁt through M-Estimation,
already implemented by the R package aﬀyPLM (19). The
array eﬀect  i includes both the technical artifact ti and
real biological eﬀect bi, so that
 i ¼ ti þ bi
but we do not try to separate these two eﬀects. Usually,
the normalization step attempts to remove the technical
artifact ti, such that the remaining signal is the biological
eﬀect plus noise. Instead, we will keep the combined
technical and biological eﬀects, with the key idea that if
the total eﬀect is not signiﬁcant, then there cannot be any
biological signal in the data, which means the gene cannot
be DE. So, the uninformative probe sets are those with
small array-to-array variations.
The array eﬀects are captured by the  2- statistic,
computed by
 2 ¼ b   0V 1b   2
where b   is the vector of estimated  i’s, and V is
its estimated covariance matrix. These quantities are
available from the robust linear model ﬁt.
A non-parametric quantile regression smoothing, with
a user-speciﬁed quantile to be estimated ( ), is ﬁtted on
the array eﬀect  2 (on the square root scale) as a function
of the logarithm of residual standard deviation (SD).
It is ‘non-parametric’ in the sense that it is not based on
an explicit functional form, but is based on local
smoothing of the data. As an option, it is possible to
use a weighted ﬁt, where weights are derived
from the cumulative function of residual SD (F(x)),
constrained to a lower bound of 1 (low residual SD
genes), with the following transformation based on two
parameters
FðxÞþ 
 
3
Setting   ¼   leads to a unit weight for probes with low
residual SD, and increasing as a function of F(x). Filtering
can be tuned by varying  ,   and  .
The estimated number of truly diﬀerentially expressed
genes (TDE), at each FDR level, was computed as 1-FDR
multiplied by the number of genes declared signiﬁcant.
Scatterplots of the t-statistics versus the logarithm of the
standard error with fdr isolines are hereafter called ‘TSE-
plots’. Fdr isolines join points with the same fdr value, and
are used to show fdr boundaries as a function of varying
SD and t-statistics (18). Plots of the square root of the
array eﬀect  2 as a function of the logarithm of the
residual SD are called ‘RA-plots’.
RESULTS
Analysisflowchart
We ﬁrst summarize (Figure 1) the work-ﬂow in the
microarray data analysis using the proposed FLUSH
algorithm. Brieﬂy:
(i) Apply FLUSH to the raw probe-level data: identify
a list of probe sets for further analysis.
(ii) Background-correct, normalize and summarize the
raw probe-level data according to the preferred
algorithm (e.g. MAS5, RMA, etc.).
(iii) Take a subset of the expression data according to
the list in Step (ii).
(iv) Perform any statistical analysis to identify DE genes
(e.g. t-test, ANOVA, etc.) among the selected
subset.
GoldenSpike data
In a recent experiment Choe et al. (14) produced a freely
available controlled spike-in data set (the ‘Golden Spike’
data set). As a ﬁrst step, the Golden Spike raw data,
brieﬂy described in the ‘Methods’ section, were processed
with FLUSH, based on a quantile regression that ﬁltered
out 60% of the probe sets (in order to identify features
to retain for the subsequent analysis). The whole data set
was background-corrected, normalized and summarized
using both MAS5 and RMA algorithms; note that this
step is not aﬀected by FLUSH. Genes ﬁltered out by
the FLUSH procedure were then removed from both the
MAS5 and RMA expression matrices. Unlike in Choe
et al., our normalization was based on all features, not just
on truly non-DE genes (those with fold change FC=1).
We did this because our purpose was to develop a
procedure that is applicable to a real experimental setting,
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present but not diﬀerentially expressed.
For comparison, we analyzed (i) unﬁltered data,
(ii) data ﬁltered according to the average-signal intensity
(iii) the variance and (iv) the Aﬀymetrix presence calls.
The idea of these ﬁlters is to remove under- or
un-expressed genes. For the intensity ﬁlter, we computed
the average intensity of each gene across the arrays after
expression measure computation and normalization, and
excluded 60% of the lowest intensity genes. The same
approach was used for the variance ﬁlter, where we
computed the genewise variance, after expression measure
and normalization, and excluded 60% of the least-varying
genes. Both MAS5 and RMA expression values were used
and compared; similar results were obtained if we changed
the proportion excluded. For the presence-call ﬁlter we
used a relatively restrictive ﬁltering, allowing only probe
sets which were declared present or marginal in at least
one sample.
To compare the spike-in versus the control groups,
we ﬁrst computed the standard t-statistic and the
associated SE, using both MAS5 and RMA expression
measures. Figure 2 shows TSE-plots without ﬁltering.
Even though all transcripts were designed to be either
over-expressed or at constant level, both RMA and MAS5
show a large number of apparently under-expressed
features, mainly due to genes with FC close to 1.
This problem arises as a consequence of unbalanced
over- and under-expressed genes, which leads to biased
normalization.
Substantial spurious over-expression signal (yellow
dots) is evident in both plots, especially in MAS5.
This is consistent with previously published analyses that
reported a signal content higher than expected (3,20)
and might be due to both non-speciﬁc binding and
normalization bias.
Figure 3 shows the plot of the square-root of the array-
eﬀect test statistic as a function of the logarithm of the
residual SD—or RA-plot—for the Golden Spike data,
showing the array-to-array variability versus residual
variance from the probe-level linear model (see
‘Methods’ section). Un-expressed genes showed
high residual variance and relatively low array-eﬀects;
these correspond to probe sets with inconsistent
patterns between replicates. Genes with FC=1 had low
array-eﬀects and relatively low residual variance,
but showed some mixing with over-expressed genes.
The majority of genes with FC >2 were clearly separated
from the cloud of noisy genes.
A non-parametric quantile regression smoothing line
(see ‘Methods’ section) was ﬁtted using the 60th percentile
of array eﬀect as a function of residual SD. As a result of
the ﬁltering procedure, a total of 8400 out of 14010
features with array eﬀects below the estimated quantile
regression line were excluded from further analysis. Given
the small sample size, the local fdr estimation through
permutation (18) is not completely trustworthy, but
the estimated local fdr can still be used to rank genes.
To assess the merits of ﬁltering and to compare the
diﬀerent procedures, we plot in Figure 4 the cumulative
number of genes declared DE at increasing values of
estimated local fdr, versus the corresponding number of
truly DE genes. For the presence-call, intensity and
Not present
MAS5 – Not Filtered
RMA – Not Filtered
1
0
−
1
−
2
l
o
g
s
e
A
B
tstat
tstat
−
3
−
4
−
5
−
1
−
2
−
3
l
o
g
s
e
−
4
−
5
−40 −20 0 20 40 60
−40 −20 0 20 40 60
0.05
0.05
0.2
0.3
0.2
0.05
0.1
0.2
0.2
0.1
0.05
0.05
0.1
FC=1
FC (1–2)
FC (2–3)
FC≥3
Not present
FC=1
FC (1–2)
FC (2–3)
FC≥3
Figure 2. TSE plot for (A) MAS5 and (B) RMA unﬁltered values.
This plot shows the standard t-statistic on the x-axis and the standard
error (in log scale) on the y-axis with additional local fdr isolines
(i.e. lines connecting points with the same local fdr value).
Array Analysis Steps using FLUSH
.cel
files FLUSH
Adjust quantile  regression parameters  (FlushSet)
Background adjust,
Normalize
(RMA or MAS5, etc.) Retain filtered probe-sets from
adjusted & normalized data  (Flush)
optional: Select subset of probe-sets
               with low local fdr  (fdr1d or fdr2d)
package affy package FLUSH
package OCplus, etc.
Figure 1. Flow-chart of the work ﬂow using FLUSH. The whole data
are background-corrected, normalized and summarized using any
algorithm, e.g. MAS5, RMA, etc. The raw data are processed with
FLUSH in order to identify probe sets to be removed in the subsequent
analysis. Identiﬁed probes are discarded from the expression matrix
prior to DE analysis.
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of genes as for FLUSH. Analyses of unﬁltered data suﬀers
from bias as well as large variability due to nonDE genes,
resulting in a high number of false discoveries. Presence-
call ﬁltering was not able to overcome the biased
normalization of non-DE genes, so in this case it
performed no better than the unﬁltered analysis. The
worst performance was demonstrated by the average-
intensity and variance ﬁltering, which clearly removed too
many truly DE genes. A more restrictive ﬁltering on
presence-call was also adopted, selecting features declared
present in at least 50% of the samples (13). This produced
similar results (see Figure 1S in the Supplementary
Report).
In contrast, FLUSH ﬁltering reduced bias, by excluding
non-DE genes that were falsely declared DE due to
imperfect normalization, and clearly increased the sensi-
tivity of the procedure based on both RMA and MAS5
expression values. For RMA analysis with unﬁltered
genes, the sensitivity was below 60% regardless of the
number of genes declared DE; FLUSH procedure
increased the sensitivity to over 80% when considering
the top ranked 550 genes declared DE and to 90% for up
to 465 genes. For MAS5 analysis with unﬁltered genes, the
sensitivity was mostly below 60%, while after ﬁltering
using FLUSH the sensitivity increased to around 80% for
the 450 genes declared DE. Interestingly, unﬁltered RMA
outperforms unﬁltered MAS5, which contrasts with Choe
et al. (14). This might be explained by the diﬀerent
normalization approach, i.e. based on the whole set of
genes rather than just the non-DE ones.
Mouse-retina degenerationmodel
We used wild-type C3H mice and inbred C3H rd1/rd1
mutant mice (15) to serve as an animal model for retinal
degenerative diseases. Retina was hybridized to
Aﬀymetrix GeneChip Mouse Genome 430 2.0 arrays,
which contain 45101 probe sets for over 39000 well-
characterized genes. As for the Golden Spike experiment,
the data were processed using both the MAS5 and RMA
algorithms, and genes were ﬁltered using FLUSH.
Figure 5 shows the RA-plots of the data. Points were
colored according to the quantiles of genes’ average
expression (on log scale), computed either with the MAS5
or RMA algorithms. Smooth lines (Figure 5C and D)
mark the ﬁltering threshold derived from a quantile
regression smoothing using   =0.4 and   ¼   ¼ 0:45
[see Equation (3)]. As we expected to have relatively few
diﬀerentially expressed genes in this experiment, we tried
to ﬁlter most un-informative probe sets. Features lying
below the ﬁtted quantile line were ﬁltered out, so that out
of 45101 probe sets, 2950 were kept. Genes with local fdr
(18) lower than 15% for unﬁltered features and 5% for
ﬁltered ones were printed with variable point size,
depending on local fdr values, with larger points having
smaller local fdr.
For a sensitivity analysis of the choice of ﬁltering
parameters, Figure 2S in the Supplementary Report shows
the RA-plot of the mouse retina data with four diﬀerent
quantile regression lines, derived from diﬀerent choices of
the tuning parameters. For this range of ﬁltering, the
results are not sensitive to the choice of ﬁltering
parameters.
Many more genes were assigned a low local fdr
value (<0.15) by the local fdr procedure (18) applied to
RMA values compared to MAS5: 73 probe sets showed
a local fdr lower or equal to 0.15 for MAS5 expression
values, and 1283 for RMA values (Figure 5A and B).
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biased, as we do not expect to see so many DE genes.
It can be seen that many features identiﬁed as DE lie in
the cloud of probe sets with low array-to-array variability
or high residual-variation, and therefore are likely false
discoveries. In Figure 5A and B individual spots are
color-coded according to probe set signal intensity; it is
worth noting that lower intensity features tend to show
lower array eﬀects and higher residual variances
compared to the high-intensity features.
Figure 5C and D show the same plots of array eﬀect
and log residual of SD after ﬁltering using FLUSH.
The FLUSH algorithm enhanced the local fdr estimation
both for MAS5 and RMA values by putting more
emphasis on genes with higher inter-array variability.
Among the FLUSH-ﬁltered DE features we recognized
39 probe sets corresponding to 27 genes known to
be regulated during retinal degeneration (21–26). A large
majority of these genes are down-regulated, which agrees
with the general model of retinal-dysfunction leading
to degradation of the photoreceptor layer which can
be observed in histological studies in rd1 mice (25).
This set of DE genes contains hallmark genes such as
RHO (rhodopsin) or PDE6B (phosphodiesterase 6B).
PDE6B was previously found to be mutated in rd1
mice (27), and thus gives a non-functional gene-product
thought responsible for the onset of retinal degeneration.
RHO is the main protein involved in detecting light and
is highly abundant in photoreceptor cells. Its abundance
decreases towards zero during the process of retinal
degeneration (25). Another key enzyme in the regenera-
tion of visual pigments, RDH12 (retinol dehydrogenase
12), was found signiﬁcantly down-regulated by both
probe sets for this gene. This gene codes for the
main enzyme involved in converting 11-cis-retinal to
11-cis-retinol in photoreceptor cells.
Figure 5. Filtering of probe sets from a mouse model of retinal degeneration. (A) and (B) show RA-plots for both MAS5 and RMA unﬁltered probe
sets. Features with fdr <0.15 have point size related to fdr values with larger dots having smaller fdr. (C) and (D) show the corresponding plots for
ﬁltered probe sets. Quantile-regression smoothing was ﬁtted with   =0.4 and  =0.45. Features with fdr <0.05 have point size related to fdr values
with larger dots having smaller fdr. In all plots, points are colored according to the average intensity computed either on MAS5 or RMA expression
values (on logarithmic scale).
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transduction and transcriptional regulation were found
DE. Among these, CRX (cone-rod homeobox) is known
to have a prominent role as photoreceptor-speciﬁc
transcription factor. In agreement with our model, CRX
was down-regulated (28,29).
Several other genes known to play key roles in retinal
function and known to be mainly expressed in retina were
identiﬁed among a stringent selection of 109 probe sets
(RMA array-eﬀect  2 > 292 with local fdr <0:027): RSG9
(regulator of G-protein signalling 9) and RPGRIP1
(retinitis pigmentosa GTPase regulator interacting protein
1) both play an important role in regulation of G-proteins
and maintaining of their proper function. Also the brain
and retina-speciﬁc G-protein GNGT1 (guanine nucleo-
tide-binding protein, gamma transducing activity poly-
peptide 1) was found down-regulated together with MAK
(male-germ cell-associated kinase) and CDR2 (cerebellar
degeneration-related protein 2). Prdx6 (peroxiredoxin 6),
whose gene product is involved in immune-response,
was found to be up-regulated, in accordance with the
stimulation of stress–response and tissue repair mechan-
isms due to retinal degeneration.
As shown in Figure 6, all 39 known probe sets are
located away from the cloud of noisy genes. Some genes
known in the context of retinal degeneration had a very
low local fdr, but were located closer to the main bulk of
points. One example is Gfap (glial ﬁbrillary acidic
protein), a well-characterized marker that is almost
exclusively expressed in astrocytes and used to follow
the progress of retinal degeneration. Overall, FLUSH
outperforms the standard FDR method without any
ﬁltering. For the RMA expression data, without any
ﬁltering, the median ranking of the standard FDR statistic
of the 39 previously mentioned probe sets was 902, i.e. the
list of 902 top-ranking genes contained only 19 of the
39 probe sets. Since we did not expect so many DE genes,
it was clear that these known probe sets were buried
among many non-DE genes. After ﬁltering with FLUSH
the median ranking was 281 (data not shown), while using
the variance ﬁlter, the median ranking was 652; this means
that variance ﬁlter is worse than FLUSH.
Variance ﬁltering applied to MAS5 expression values
retained only 12 of the 39 probe sets, which means we are
likely to lose a lot of DE genes, so we should not use this
ﬁlter. To understand what happens, Figure 7 shows
the location of the genes retained by variance ﬁltering in
the RA plot. Comparison with Figure 3 suggests strongly
that a large proportion of these genes are likely
unexpressed, and inclusion of such genes leads to loss of
sensitivity.
Additionally, we compared our results with an alter-
native ﬁltering based on the GC-RMA algorithm (30).
Using this approach we typically observe a bimodal
histogram of intensity values. Since the ﬁrst of these peaks
is (i) very sharp and (ii) part of the lowest signal intensity,
it is tempting to associate this peak with non-expressed
genes (data not shown). Removing all probe sets with
average signal intensity in the ﬁrst peak (ﬁxed threshold
of 4.8) gave 21231 probe sets. [These correspond to 11803
diﬀerent genes, a slightly larger number than the estimate
of 9100-9200 genes expressed in the retina (31).]
With this ﬁlter, the median ranking of standard FDR
for the 39 probe sets mentioned above was 998. So,
although the histogram-based procedure for GC-RMA
removes a large proportion of non-DE probe sets, many
unlikely DE probe sets still remain, and thus yield a very
high median ranking for the 39 validated probe sets.
DISCUSSION
This article shows a novel data analytic procedure, called
FLUSH, for ﬁltering out potentially uninformative genes
in Aﬀymetrix microarrays and selecting features with
Figure 6. RA-plots of the retina degradation data, where we highlight
the probe sets known or suggested to be diﬀerentially regulated in rd1
mouse retina at post-natal day 15. Such probe sets are plotted as solid
black points and marked with their respective gene symbol.
Figure 7. RA-plot of the retina degradation data, where we
highlight the probe sets (red points) retained by the variance ﬁltering.
In view of Figure 3, these probe sets are likely to correspond
to unexpressed genes.
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as a ﬁltering procedure performed in conjunction with any
pre-processing step such as normalization and prior to any
statistical or DE analysis. The main motivation is that
a large proportion of genes on a microarray are un-
expressed or non-DE, and these genes make it harder to
detect DE genes, so they should be excluded prior to DE
analysis. We have shown that FLUSH performs better
than other more ad hoc ﬁltering methods based on
presence-call or signal intensity. To highlight the novel
contributions of FLUSH:
  FLUSH operates on raw un-normalized probe-level
data, so it is not aﬀected by the biases due to the
imperfect normalization step. In fact, the analysis of
the spike-in data shows that FLUSH can reduce the
eﬀect of biased normalization.
  FLUSH is based on the same robust statistical model
that provides the RMA expression values, so FLUSH
will have the same broad utility as the RMA
methodology.
  FLUSH produces an informative residual-array
(RA) plot that captures the probe-pattern consistency
and array-to-array variation. Experience with spike-in
and real data suggests that true discoveries are to be
found among the extreme points in this plot, so
scrutiny of this plot should be part of routine data
analysis.
Conceptually, the ﬁltering method we used here can be
adapted to other types of microarray data, such cDNA or
bead arrays, as long as there are replications for each gene
to allow separation of within- and between-array variance.
(The within-array variance is the residual variance.)
However, because of the assumed data structure,
the speciﬁc implementation of the method and the R
package reported in this article can be applied only to
Aﬀymetrix data.
A recent theoretical computation (32) showed that there
is an optimal number of hypotheses to be tested that is
limited by the number of samples in the experiment.
As seen clearly with the data examples, when the
proportion of DE genes is small, they tend to get buried
among the non-DE genes, thus increasing the FDR.
Filtering out likely non-DE genes is a practical solution to
this problem.
Our analysis is based on a robust linear model, so it is
not aﬀected by outliers generated by some bad samples.
Note that the analysis is performed gene by gene, so at any
one analysis we expect only a few outliers. Nevertheless,
we would recommend that the standard quality control
checks for the arrays are followed.
We emphasize that our purpose is not to show whether
MAS5 or RMA work for Choe’s data, but whether we
gain anything by using FLUSH. In principle, FLUSH can
be used with any normalization method. With spike-in
data such as Choe’s, it is possible to normalize using the
ideal FC1-genes, but this is not feasible in real experi-
ments, where ﬁnding FC1 genes requires pre-processed
data including the normalization step, so there is a vicious
cycle between normalization and ﬁnding FC1 genes.
Normalization with MAS5 or RMA is usually applied
to the full set of genes. The so-called ‘housekeeping-gene
normalization’ for MAS5, using the a priori set of FC1
genes, was shown to be biased in Ploner et al. (33). When
the FC1-gene normalization was used for RMA as in
Choe’s et al. (14), ﬁltering using FLUSH still improves the
performance of DE analysis.
In most clinical data, the pattern of over/under-
expressed genes tends to be balanced. But in lab
experiments, e.g. with knock-out mice, an unbalanced
proportion of over/under-expressed genes may reasonably
happen. Haslett et al. (34), for example, reported a
relevant bias towards over-expression in muscle-related
genes (135 of the 185 declared DE). A similar unbalanced
pattern was reported in other works (35–38). Such
unbalanced over- and under-expression violates the key
assumption of balanced expression for the normalization
step in data pre-processing. In this situation, both RMA
and MAS5 expression measures will be biased due to
imperfect normalization. FDR estimation and the sensi-
tivity of the test will be aﬀected by the bias in the
pre-processing procedures. The problem is that, with real
data sets, it is not obvious whether all the genes have been
properly normalized. Even in clinical data with balanced
expression levels, Ploner et al (33) showed that the
commonly used quantile normalization is biased for
low-intensity genes.
Existing ﬁltering methods based on Aﬀymetrix
presence-calls may be useful for removing noisy signal
both for MAS5 and RMA values, but as shown in the
Golden Spike data analysis, it cannot overcome all
possible biases. The proposed FLUSH algorithm ﬂexibly
discards likely uninteresting features in terms of low
information content (between-array variability), and
lack of consistency among probe-pairs within probe sets
(residual variance). Unlike variance ﬁltering, FLUSH
operates at the raw un-normalized probe-level data, thus
it is not aﬀected by the possible bias due to imperfect
normalization. From our experience, low intensity genes
tend to have higher residual variability, i.e. more
inconsistent hybridization patterns across the experimen-
tal replicates. FLUSH can account for intensity, since we
can use a ﬂexible weight to penalize high residual variance,
which is associated with low intensity features.
Filtering genes prior to DE analysis might be viewed
with some suspicion, as important diﬀerentially regulated
features might be lost. There is obviously a sensitivity-
speciﬁcity trade-oﬀ, since without ﬁltering the great
amount of spurious signals present in microarray data
will make it hard to detect the real information.
Software
All of the statistical analyses was performed using R (39)
and Bioconductor (40). The package aﬀyPLM (19) was
used for probe-level robust linear model ﬁtting. A freely-
available R package called FLUSH implements the
procedures and graphical displays described in the
paper. The package is available at the authors’ website
http://www.meb.ki.se/
 yudpaw.
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